Showing results (671-680 of 725) with videos related to
Sort By:
Pageof 73
The European Respiratory Journal|August 27, 2021
Identification of asthma-associated microRNAs in bronchial biopsiesMirjam P Roffel, Ilse M Boudewijn, Jos L L van Nijnatten, et al.Neuromuscular Disorders : NMD|November 18, 2005
The differential gene expression profiles of proximal and distal muscle groups are altered in pre-pathological dysferlin-deficient miceMaja von der Hagen, Steven H Laval, Lynsey M Cree, et al.Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|December 18, 2023
Invasive group A streptococcal disease surveillance in Canada, 2020Alyssa Golden, Averil Griffith, Walter Demczuk, et al.Plos One|May 23, 2017
Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencingWalter H B Demczuk, Irene Martin, Linda Hoang, et al.Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|December 21, 2023
Invasive pneumococcal disease surveillance in Canada, 2020Alyssa Golden, Averil Griffith, Walter Demczuk, et al.European Journal of Cancer (Oxford, England : 1990)|June 26, 2012
Perceptions of genetic research and testing among members of families with an increased risk of malignant melanomaRichard Bränström, Nadine A Kasparian, Paul Affleck, et al.Plos One|July 22, 2017
Integrating cervical cancer with HIV healthcare services: A systematic reviewLouise Sigfrid, Georgina Murphy, Victoria Haldane, et al.Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|June 5, 2024
Invasive group A streptococcal disease surveillance in Canada, 2021-2022Alyssa R Golden, Averil Griffith, Gregory J Tyrrell, et al.Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|June 5, 2024
Invasive pneumococcal disease surveillance in Canada, 2021-2022Averil Griffith, Alyssa R Golden, Brigitte Lefebvre, et al.Trials|September 2, 2024
Collecting and reporting adverse events in low-income settings-perspectives from vaccine trials in the GambiaAndrew Ayi-Ashong Bruce, Ama-Onyebuchi Umesi, Adedapo Bashorun, et al.Pageof 73